These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33116484)

  • 81. Streptomycin sulphate loaded solid lipid nanoparticles show enhanced uptake in macrophage, lower MIC in Mycobacterium and improved oral bioavailability.
    Singh M; Schiavone N; Papucci L; Maan P; Kaur J; Singh G; Nandi U; Nosi D; Tani A; Khuller GK; Priya M; Singh R; Kaur IP
    Eur J Pharm Biopharm; 2021 Mar; 160():100-124. PubMed ID: 33497794
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors.
    Khalili M; Zhou H; Thadi A; Daniels L; Fan Z; Morano WF; Ang J; Goldstein E; Polyak B; Mapow BC; Cheng H; Bowne WB
    Ann Surg Oncol; 2020 Jan; 27(1):76-84. PubMed ID: 31187366
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Preparation and characterization of lutein loaded folate conjugated polymeric nanoparticles.
    Bolla PK; Gote V; Singh M; Yellepeddi VK; Patel M; Pal D; Gong X; Sambalingam D; Renukuntla J
    J Microencapsul; 2020 Nov; 37(7):502-516. PubMed ID: 32842813
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
    Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
    J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection.
    Xie B; Liu Y; Guo Y; Zhang E; Pu C; He H; Yin T; Tang X
    Pharm Res; 2018 Feb; 35(3):62. PubMed ID: 29445971
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
    He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J
    Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacokinetics and in vivo distribution of optimized PLGA nanoparticles for pulmonary delivery of levofloxacin.
    Shah SR; Prajapati HR; Sheth DB; Gondaliya EM; Vyas AJ; Soniwala MM; Chavda JR
    J Pharm Pharmacol; 2020 Aug; 72(8):1026-1037. PubMed ID: 32337714
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.
    Rifat D; Prideaux B; Savic RM; Urbanowski ME; Parsons TL; Luna B; Marzinke MA; Ordonez AA; DeMarco VP; Jain SK; Dartois V; Bishai WR; Dooley KE
    Sci Transl Med; 2018 Apr; 10(435):. PubMed ID: 29618565
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
    Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
    Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages.
    Pei Y; Mohamed MF; Seleem MN; Yeo Y
    J Control Release; 2017 Dec; 267():133-143. PubMed ID: 28797580
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles.
    Simón-Vázquez R; Tsapis N; Lorscheider M; Rodríguez A; Calleja P; Mousnier L; de Miguel Villegas E; González-Fernández Á; Fattal E
    Drug Deliv Transl Res; 2022 May; 12(5):1270-1284. PubMed ID: 34993924
    [TBL] [Abstract][Full Text] [Related]  

  • 93. An
    Gajbhiye KR; Soni V
    Curr Drug Deliv; 2023; 20(7):961-977. PubMed ID: 35578875
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis.
    Campos Pacheco JE; Yalovenko T; Riaz A; Kotov N; Davids C; Persson A; Falkman P; Feiler A; Godaly G; Johnson CM; Ekström M; Pilkington GA; Valetti S
    J Control Release; 2024 May; 369():231-250. PubMed ID: 38479444
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells.
    Jalilzadeh N; Samadi N; Salehi R; Dehghan G; Iranshahi M; Dadpour MR; Hamishehkar H
    Sci Rep; 2020 Jan; 10(1):1606. PubMed ID: 32005894
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Multimetallic Microparticles Increase the Potency of Rifampicin against Intracellular Mycobacterium tuberculosis.
    Ellis T; Chiappi M; García-Trenco A; Al-Ejji M; Sarkar S; Georgiou TK; Shaffer MSP; Tetley TD; Schwander S; Ryan MP; Porter AE
    ACS Nano; 2018 Jun; 12(6):5228-5240. PubMed ID: 29767993
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study.
    Keung AC; Owens RC; Eller MG; Weir SJ; Nicolau DP; Nightingale CH
    Antimicrob Agents Chemother; 1999 May; 43(5):1230-3. PubMed ID: 10223941
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Levofloxacin-Loaded Nanosonosensitizer as a Highly Efficient Therapy for Bacillus Calmette-Guérin Infections Based on Bacteria-Specific Labeling and Sonotheranostic Strategy.
    Li G; Li J; Hou Y; Xie S; Xu J; Yang M; Li D; Du Y
    Int J Nanomedicine; 2021; 16():6553-6573. PubMed ID: 34602818
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages.
    Barrow EL; Winchester GA; Staas JK; Quenelle DC; Barrow WW
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2682-9. PubMed ID: 9756777
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study.
    Lim JM; Bertrand N; Valencia PM; Rhee M; Langer R; Jon S; Farokhzad OC; Karnik R
    Nanomedicine; 2014 Feb; 10(2):401-9. PubMed ID: 23969105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.